Future Market Insights has announced the addition of the AIDS Related Primary CNS Lymphoma Market,2016-2026
Future Market Insights has announced the addition of the “AIDS Related Primary CNS Lymphoma Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Acquired immunodeficiency syndrome (AIDS) is a viral disease of immune system caused by the infection of human immunodeficiency virus (HIV). Primary central nervous system lymphoma (PCNSL) is a primary intracranial tumor occurs mostly in patients suffering from severe immunosuppression specifically AIDS. The pathogen responsible for primary CNS lymphoma is Epstein-Barr virus. AIDS associated primary CNS lymphoma diffuses large-cell lymphoma of B-cell which usually occurs in brain or spinal cord. Patients suffering from CNS lymphoma complain about lethargy, headache, neurologic symptoms and signs and changes in mental status. For diagnosing AIDS associated primary CNS lymphoma, Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) is performed. Biopsy diagnosis is also performed to confirm the results as the lesions reported in MRI and CT scan sometimes generate confusion between toxoplasmosis, progressive multifocal leukoencephalopathy (PML) lesions and lymphoma.
AIDS — Related Primary CNS Lymphoma Market: Drivers and Restraints
The market is expected to witness high growth during the forecast period as number of AIDS patients are increasing across the globe. Likewise, increasing awareness initiatives by government authorities would propel the growth of AIDS - related primary CNS lymphoma market. Also, many pharmaceutical companies are entering into market for developing and manufacturing drugs for preventing and treating AIDS- related primary CNS lymphoma.
Request free sample Report: www.futuremarketinsights.com/reports/sample/rep-gb-1400
AIDS — Related Primary CNS Lymphoma Market: Segmentation
AIDS — related primary CNS lymphoma market is classified on the basis of drug type, distribution channel and geography.
Based on the drug type, the global market for AIDS — related primary CNS lymphoma is segmented into the following:
Based on the distribution channel the global market for AIDS - related primary CNS lymphoma is segmented into the following:
- Hospitals Clinics
- Private Clinics
- Retail Pharmacies and Drug Stores
Based on the geography the global market for AIDS — related primary CNS lymphoma is segmented into the following:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific
- Middle East and Africa
Request for TOC: www.futuremarketinsights.com/toc/rep-gb-1400
AIDS — Related Primary CNS Lymphoma Market: Overview
Chemotherapy and radiation therapy are administered for treatment of AIDS — related primary CNS lymphoma. AIDS - related primary CNS lymphoma. Various drugs have been utilized during chemotherapy sessions include methotrexate, thiotepa and procarbazine. For increasing treatment efficiency, rituximab is combined with methotrexate. Temozolomide is also used with those patients who demonstrate fair response to the treatment. The major therapy used for treating AIDS associated primary CNS lymphoma is Highly Active Antiretroviral Therapy (HAART). Moreover, several clinical trials are being conducted in order to develop and commercialize more precise and exclusive treatments for the condition.
AIDS — Related Primary CNS Lymphoma Market: Region-wise Outlook
Depending on geographic regions, global AIDS — related primary CNS lymphoma market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America and Eastern Europe markets are currently at the maturity stage for clinical research and methods for treating AIDS associated primary CNS lymphoma due to their position to use expensive drugs and treatment. However, Asia-Pacific market looks attractive for AIDS associated primary CNS lymphoma treatment owing to increasing awareness among the people about the treatment availability. Considering the treatment types, HAART occupies the major market share among the other available treatments. The institutes which are majorly involved in clinical research for AIDS associated primary CNS lymphoma treatments are the National Cancer Institute, National Institute of Allergy and Infectious diseases, AIDS Malignancy Clinical Trials Consortium, European Organization for Research and Treatment of Cancer and Eastern Cooperative Oncology Group.
Browse full report: www.futuremarketinsights.com/reports/aids-related-primary-cns-lymphoma-market
AIDS — Related Primary CNS Lymphoma Market: Key Players
Some of the key players in global AIDS — related primary CNS lymphoma market are Fresenius SE & Co. KGaA, Amgen Inc., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Celon Laboratories Limited among several others.